US Gives Full Approval To Antiviral Remdesivir To Treat Covid-19
Sumaira FH Published October 23, 2020 | 01:48 PM
The US Food and Drug Administration on Thursday granted full approval to the antiviral drug remdesivir as a treatment for patients hospitalized with Covid-19, after conditional authorization was given in May
Washington, (APP - UrduPoint / Pakistan Point News - 23rd Oct, 2020 ) :The US food and Drug Administration on Thursday granted full approval to the antiviral drug remdesivir as a treatment for patients hospitalized with Covid-19, after conditional authorization was given in May.
Gilead said the drug, sold under the brand name Veklury, was the only specific treatment for Covid-19 approved so far under a more rigorous process.
However, other treatments have received authorization for emergency use, though that approval can be revoked once the public health emergency sparked by the coronavirus pandemic is over.
Other medications, like the steroid dexamethasone, are also being used in the fight against Covid-19.
Gilead's shares on the New York Stock Exchange jumped four percent soon after the announcement.
"The FDA is committed to expediting the development and availability of Covid-19 treatments during this unprecedented public health emergency," said FDA Commissioner Stephen Hahn.
"Today's approval is supported by data from multiple clinical trials that the agency has rigorously assessed and represents an important scientific milestone in the Covid-19 pandemic.
" Europe and other countries such as Canada also have granted temporary approval for the use of remdesivir.
Remdesivir, which is administered by an injection, was one of the first drugs to show relative promise in shortening the time to recovery in some coronavirus patients.
But its efficacy in reducing the mortality rate is unproven.
It can be administered to adults and children over the age of 12 who weigh more than 40 kilos (88 Pounds) who require hospitalization for the treatment of Covid-19, the illness caused by the novel coronavirus.
The drug can only be given to patients in a hospital or equivalent setting.
Emergency approval has been granted for its use on pediatric patients under the age of 12 weighing at least 3.5 kilos.
President Donald Trump, who tested positive for the coronavirus early in October, was treated with remdesivir at a military hospital outside Washington, among other drugs.
Related Topics
Recent Stories
PTI to stage nationwide protests against alleged electoral frauds
Senate continues discussion on Presidential address to Joint Sitting of Parliame ..
Masood Khan calls for Pak-US cooperation for regional peace
Interior Minister starts Margalla Trail Patrol for security
Currency Rate In Pakistan - Dollar, Euro, Pound, Riyal Rates On 26 April 2024
Today Gold Rate in Pakistan 26 April 2024
ICC Womens T20 World Cup Qualifier, Match 2: Ireland Women open with Comfortable ..
Robinson, bowlers help New Zealand go 2-1 up against Pakistan
Shahzeb Chachar to hold khuli kachehri on April 26
Heatwave amid Israel's aggression in Gaza brings new misery, disease risk
Tourism must change, mayor says as Venice launches entry fee
Court adjourns Judicial Complex attack case till May 17
More Stories From World
-
Cybersecurity firm Darktrace accepts $5 bn takeover
3 minutes ago -
Clean energy drives massive BHP takeover bid
33 minutes ago -
Copper price tops $10,000 for first time in two years
53 minutes ago -
Ukraine agriculture minister held for alleged corruption
1 hour ago -
China calls Germany spy claims 'pure fabrication'
1 hour ago -
Singapore expects 1-3 pct growth this year
1 hour ago
-
Hong Kong's Hang Seng Tech Index rises over 5 pct
1 hour ago -
New Zealand business sector R&D expenditure hits 2.21 bln USD
1 hour ago -
3 dead after mini car falls into west Japan paddy field
1 hour ago -
Chinese shares higher at midday Friday
1 hour ago -
Myanmar plans to export 2,000 tons of coffee in 2024-25 fiscal year
2 hours ago -
Chinese shares close higher Friday
2 hours ago